CRISPR Therapeutics (CRSP) Operating Margin (2016 - 2026)
CRISPR Therapeutics (CRSP) operating margin from Mar 31, 2016 to Mar 31, 2026. The current CRISPR Therapeutics (CRSP) operating margin is -8921.23%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of CRISPR Therapeutics (CRSP)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -18933.62% | +1414.06% |
| 2024 | -1250.52% | +1985.95% |
| 2023 | -59.95% | -99.89% |
| 2022 | -56096.67% | -137508.52% |
| 2021 | 40.82% | -100.08% |
| 2020 | -49226.39% | -305095.08% |
| 2019 | 16.14% | -75.42% |
| 2019 | 65.66% | -100.38% |
| 2019 | -17181.25% | +17.10% |
| 2019 | -14672.73% | +188.03% |
| 2018 | -5094.23% | -42.29% |
| 2018 | -8826.79% | +158.01% |
| 2018 | -3421.10% | +72.32% |
| 2018 | -1985.29% | +1159.04% |
| 2017 | -157.68% | -84.01% |
| 2017 | -986.19% | +65.68% |
| 2017 | -595.25% | -22.51% |
| 2017 | -768.15% | -41.82% |
| 2016 | -1320.35% | +40.08% |
| 2016 | -942.58% | -54.46% |
| 2016 | -2070.00% | -14.71% |
| 2016 | -2427.08% | -76.42% |
| 2015 | -10292.00% | N/A |
Comparison CRISPR Therapeutics (CRSP) operating margin with competitors
CRISPR Therapeutics (CRSP) operating margin is -8921.23%.